Cargando…
Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro
Ebola virus is the causative agent of Ebola virus disease, a severe, often fatal illness in humans. So far, there are no US Food and Drug Administration (FDA)-approved therapeutics directed against Ebola virus. Here, we selected the host factor Niemann-Pick C1 (NPC1), which has been shown to be esse...
Autores principales: | Sadewasser, Anne, Dietzel, Erik, Michel, Sven, Klüver, Michael, Helfer, Markus, Thelemann, Tamara, Klar, Richard, Eickmann, Markus, Becker, Stephan, Jaschinski, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529764/ https://www.ncbi.nlm.nih.gov/pubmed/31125846 http://dx.doi.org/10.1016/j.omtn.2019.04.018 |
Ejemplares similares
-
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
por: Javanbakht, Hassan, et al.
Publicado: (2018) -
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
por: Carette, Jan E., et al.
Publicado: (2011) -
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
por: Wang, Han, et al.
Publicado: (2016) -
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
por: Kashyap, Abhishek S., et al.
Publicado: (2019) -
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
por: Gong, Xin, et al.
Publicado: (2016)